Sabra Health Care REIT (NYSE:WELL) (NASDAQ: SBRA) has reported a positive trajectory in its first-quarter earnings call, highlighting growth in key areas and reaffirming its full-year 2024 guidance. The company's financial results showed an improvement in operating performance with skilled nursing EBITDA and coverage surpassing pre-pandemic levels.
Senior housing triple net lease coverage is also on an upward trend, nearing pre-pandemic figures. Sabra Health Care REIT announced its intention to reveal new acquisition deals in the upcoming second quarter earnings call.
Key Takeaways
- Sabra Health Care REIT's skilled nursing EBITDA and coverage have exceeded pre-pandemic levels.
- The company's senior housing triple net lease coverage is improving, approaching pre-pandemic levels.
- Revenue and cash net operating income in the managed senior housing portfolio have grown due to increased demand, occupancy, and reduced expenses.
- Sabra Health Care REIT reported normalized FFO and normalized AFFO per share at $0.34 and $0.35, respectively, a 3% year-over-year increase.
- The company has reaffirmed its full-year 2024 guidance for net income, FFO, normalized FFO, adjusted FFO, and normalized adjusted FFO.
- A quarterly cash dividend of $0.30 per share of common stock was declared.
- CEO Rich Matros criticized the CMS minimum staffing ruling as impractical and anticipates legal and legislative action to overturn it.
Company Outlook
- Sabra Health Care REIT expects to announce new deals in the second quarter earnings call.
- The company has an acquisition pipeline and plans to use stock, line of credit, or sales proceeds for funding.
- Full-year 2024 guidance ranges for key financial metrics have been reaffirmed.
Bearish Highlights
- The CMS minimum staffing ruling was criticized by CEO Rich Matros, who deemed it impractical due to labor shortages.
- The company is preparing for potential legal and legislative challenges to address the CMS ruling.
Bullish Highlights
- The managed senior housing portfolio is performing well, ahead of internal forecasts, with expected mid-teens growth on an NOI basis year-over-year.
- The SHOP portfolio is not facing significant labor issues and has hired enough staff to meet occupancy goals.
Misses
- There are concerns about the impact of the CMS minimum staffing ruling on the portfolio, although the extent is unclear.
- The IL portfolio had a greater impact on revenue, while the IO portfolio was less affected by the pandemic.
Q&A Highlights
- CEO Rich Matros discussed the impracticality of the CMS staffing ruling and its one-size-fits-all approach.
- Matros emphasized that the rule's impact on their portfolio would vary by market, but most buildings are well-staffed.
- The phase-in for the CMS rule will not start for two years, leaving time to assess the full impact on operations.
In conclusion, Sabra Health Care REIT's first-quarter earnings call painted a picture of resilience and growth, despite the looming challenges posed by regulatory changes. The company's proactive stance on acquisitions and financial stability, coupled with a strong operational performance, sets the stage for its future endeavors. With plans to expand and a robust financial outlook, Sabra Health Care REIT remains a notable player in the healthcare real estate investment trust sector.
InvestingPro Insights
Sabra Health Care REIT (NASDAQ: SBRA) has demonstrated a strong financial performance in the last twelve months, and current metrics from InvestingPro suggest a continued positive trend. Here are some insights based on the latest data:
- The company boasts a market capitalization of approximately $3.35 billion USD, reflecting its significant presence in the healthcare real estate investment trust market.
- Sabra's revenue has shown healthy growth, with a 22.2% increase in the last twelve months as of Q1 2024. This uptick in revenue is indicative of the company's operational efficiency and market demand for its services.
- A noteworthy InvestingPro Tip is that the company is expected to maintain its growth trajectory, with net income predicted to increase this year. This aligns with the company's robust revenue growth and may provide confidence to investors looking for stable income-generating assets.
Moreover, Sabra's commitment to shareholders is evident through its dividend policy. The company has a high dividend yield of 8.28% as of the latest data, and it has consistently paid dividends for 14 consecutive years, which is a testament to its financial stability and reliability as an income investment.
Investors interested in deeper analysis and more InvestingPro Tips can find additional insights and metrics on https://www.investing.com/pro/SBRA. For those looking to subscribe, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription. There are 9 additional InvestingPro Tips available, offering a comprehensive view of Sabra Health Care REIT's investment potential.
Full transcript - Sabra Healthcare REIT Inc (NASDAQ:SBRA) Q1 2024:
Operator: Good day everyone. My name is Katherine and I will be your conference operator today. At this time, I would like to welcome everyone to the Sabra Health Care REIT First Quarter Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions] Now I would like to turn the call over to Lukas Hartwich, SVP Finance. Please go ahead Mr. Hartwich.
Lukas Hartwich: Thank you, and good morning. Before we begin, I want to remind you that we will be making forward-looking statements in our comments and in response to your questions concerning our expectations regarding our future financial position and results of operations including reiterating our earnings guidance for 2024, expectations regarding our tenants and operators and our expectations regarding our acquisition, disposition and investment plans. These forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could cause actual results to differ materially including the risks listed in our Form 10-K for the year ended December 31, 2023 as well as in our earnings press release included as Exhibit 99.1 to the Form 8-K we furnished to the SEC yesterday. We undertake no obligation to update our forward-looking statements to reflect subsequent events or circumstances, and you should not assume later in the quarter that the comments we make today are still valid. In addition, references will be made during this call to non-GAAP financial results. Investors are encouraged to review these non-GAAP financial measures as well as the explanation and reconciliation of these measures to the comparable GAAP results included on the Financials page of the Investors section of our website at sabrahealth.com. Our Form 10-Q, earnings release and supplement can also be accessed in the Investors section of our website. And with that, let me turn the call over to Rick Matros, CEO, President and Chair of Sabra Health Care REIT.
Rick Matros: Thanks Lukas. Thanks everybody for joining us. Hope you all have a good day. So this quarter is really just a continuation of the last couple of quarters. Our operating performance continues to improve. Our balance sheet strength has us in a position to grow. Our skilled nursing EBITDA and coverage continues to nut job exceeding pre-pandemic coverage. Our senior housing triple net lease coverage continues to improve that is near pre-pandemic levels. Our top 10 is stronger than it's ever been. Our skilled occupancy is up 110 basis points sequentially and our skilled mix is higher than it's been in several quarters. Our senior housing triple net occupancy is higher than pre-pandemic occupancy. Our SHOP growth continues with occupancy higher than it's been since the early months of the pandemic. Contract labor continues to improve dropping to where we were three years ago, well-below peak levels although still higher than we want to see. Our deal flow is improving and notes primarily SHOP we are finally starting to see some skilled nursing opportunities. In both Skilled and SHOP sales pricing has moved towards buyers. While we don't have new investments to announce this quarter based on current activity, we expect to be in a position to announce new deals on our second quarter earnings call. We are running better than anticipated on our forecast including our SHOP performance. But since it's still very early in the year we're going to wait until Q2 to reassess our guidance. And with that, I'll turn the call over to Talya.
Talya Nevo-Hacohen: Thank you, Rick. Sabra's managed senior housing portfolio including joint ventures at share continues to perform well. The portfolio grew by five communities during the quarter and seven communities year-over-year, which were all properties previously leased to other operators and I underscore leased. While the added community has had a limited contribution to the total, Sabra's managed portfolio saw a 16.5% quarterly revenue growth and just over 26% quarterly cash net operating income growth on a year-over-year basis. This was driven by the trends that we've been noting for the past several quarters. Growing demand at driving occupancy and REVPOR gains and moderating expenses. Wage growth has decelerated as open positions are filling together, reducing overtime needs and even eliminating agency usage. Sabra's same-store manage the inner housing portfolio including joint ventures at Chair [ph] includes 64 properties, 43 of which are in the US and the balance in Canada. Excluding non-stabilized assets and government stimulus, the headline numbers are same-store portfolio revenue for the quarter grew 5.8% year-over-year with our Canadian communities growing revenue by 9.2%. Cash NOI for the quarter grew 9.5% over the first quarter of 2023, skewed down by a lower than usual expense item in the first quarter of 2023. Cash NOI for the quarter increased 16.7% in our Canadian communities. REVPOR's first quarter of 2024 increased by 3.4% year-over-year with REVPOR in our Canadian portfolio growing by 5.1% in the period. The senior housing recovery in Canada has been lacked in the US and is now catching up. Drivers of revenue growth in our Canadian community outpaced our US communities this past quarter on a year-over-year basis while expense growth has come into line with our US community particularly on a sequential quarter basis. Our net lease stabilized senior housing portfolio continues to thrive with occupancy for the past quarter at about 90% as Rick said above pre-pandemic levels and steadily improving rent coverage. Sabra's total investment in behavioral health remained approximately $800 million as we provide time for our assets to complete conversion and lease up and reach stabilization. You will note that we have combined specialty hospitals and behavioral health in our coverage disclosure in our supplemental because combined these categories represent 21 stabilized properties contributing about 10.5% of Sabra's NOI with only six behavioral properties in there. And with that I will turn the call over to Michael Costa Sabra's Chief Financial Officer.
Michael Costa: Thanks, Talya. For the first quarter of 2024, we recognized normalized FFO per share of $0.34 and a normalized AFFO per share of $0.35 both up $0.02 from our fourth quarter 2023 results. Year-over-year both normalized FFO per share and normalized AFFO per share increased 3% representing the first year-over-year increase in both since before the pandemic. This sequential increase was driven by the following: a $1.8 million sequential increase in cash rents received with the majority coming from stronger collections from cash basis tenants compared to the fourth quarter. A $1.3 million reduction in normalized cash G&A expense primarily related to performance-based compensation true-ups that occurred in the fourth quarter. $900,000 of business interruption insurance income related to a property that suffered fire damage last year and a $600,000 improvement in NOI from our managed senior housing portfolio due to improved performance as well as the transition of five facilities to our managed portfolio that were previously leased on a triple-net basis. This was partially offset by a $500,000 increase in cash interest expense due to higher outstanding borrowings under our revolving credit facility. As Rick noted earlier, our first quarter performance came in slightly better than what we had forecast in our 2024 guidance estimate. While we are pleased with this out performance given that it's early in the year, we feel it's most prudent to reaffirm our full year 2024 guidance ranges at this time and we will revisit these ranges for our second quarter earnings call. Our full year 2024 guidance ranges on a diluted per share basis are as follows: net income $0.53 to $0.57 FFO $1.33 to $1.37 Normalized FFO $1.34 to $1.38 Adjusted FFO $1.38 to $1.42 normalized adjusted FFO of $1.39 to $1.43. As a reminder our guidance does not assume any acquisition or disposition activity. Now briefly turning to our balance sheet. Our net debt to adjusted EBITDA ratio was 5.55x as of March 31, 2024. As our portfolio continues its recovery from the pandemic, we expect this to result in improvements to both our earnings as well as our leverage. As of March 31, 2024, we are in compliance with all of our debt covenants and have ample liquidity of $914 million consisting of unrestricted cash and cash equivalents of $60 million and available borrowings of $854 million under our revolving credit facility. Finally, on May 8, 2024, Sabra's Board of Directors declared a quarterly cash dividend of $0.30 per share of common stock. The dividend will be paid on May 31 2024 to common stockholders of record as of the close of business on May 20, 2024. The dividend is adequately covered and represents a payout of 86% of our first quarter normalized AFFO per share and this payout percentage is expected to improve over the course of 2024. And with that, we'll open up the lines for Q&A.
Operator: [Operator Instructions] Your first question comes from the line of Austin Wurschmidt from KeyBanc. Please go ahead.
Austin Wurschmidt: Hey good morning everybody. Just wanted to hit on the SHOP and just with respect to that I wanted to clarify the low to mid-teens that you said kind of felt right last quarter. I know you didn't provide explicit guidance but kind of pointed towards that low to mid-teens growth does that include the contribution from the unconsolidated joint venture portfolio? And is that a same-store figure?
Michael Lourenco: It does include the contribution from the joint ventures and it's not a same-store number. It's a year-over-year number on a comparative basis.
Austin Wurschmidt: Got it. So, this includes the benefit from the transition of these from AAA lease to facilities that are now moved from a triple-net lease to the RIDEA structure?
Michael Lourenco: That's right. And if you also think about it these were triple net assets before that we transitioned. They weren't performing a triple net assets. They weren't contributing anything to our NOI in 2023.
Austin Wurschmidt: Got it. That's helpful. And then just another one for me clarification. So, has there been any change to the cash NOI contribution from Signature Healthcare? It looked like the quarterly cash NOI number came down a bit. So just curious if there's anything there.
Michael Lourenco: Yes. It was just a timing issue really. It was just a timing issue in the first quarter. Since we're on a cash basis we recorded revenues when the cash comes in the door. And part of the March payment came in shortly after March 31 that simply as.
Austin Wurschmidt: So, there'll be a catch-up payment that gets them on par with the prior kind of quarterly run rate in the second quarter that we should expect?
Michael Lourenco: Yes, got it. Thank you.
Operator: Your next question comes from the line of Joshua Dennerlein of Bank of America (NYSE:BAC). your line is open.
Joshua Dennerlein: Rick just wanted to kind of get your take on the final minimum staffing ruling from the CMS. How do you think this plays out from here? And then just curious like how we should I know it's a couple of years out with the phase and just like how should we think about potential impact on your portfolio?
Rich Matros: Okay if it doesn't get over-turn I think the same as we've been saying all along and that is the rule is ludicrous on the space simply because the labor isn't available. And as I think -- as I've stated in the past that now it's been publicly stated by the industry and the trade association you can expect to see both legal legislative action to overturn this.
Joshua Dennerlein: Okay. And if it doesn't get overturned or like stays as is like is there any kind of thought process on how it might impact like your portfolio your operators? Or are you just saying they just like won't be able to even find the labor?
Rich Matros: Well it depends on the market. Most of our buildings are actually in pretty good shape relative to it and I think higher than national average from a staffing perspective. But as you noted even if we sort of stay in place it's a phase-in process that's not going to start for two years. It's -- you're not too for another couple of years. And labor has been improving certainly contract labor as I noted has improved dramatically. And so presumably things will improve more. So it's a little bit hard to anticipate. But it isn't just a matter of putting a number out there that's going to be a lot of operators in certain markets completely unable to fill positions. And so it's -- really got nothing to do with quality of care. It's got everything to do with punishing nursing books. That's what that's really what it's about. And the other point that's really critical here is it's a one size fits all. And even in the final rule they really didn't address the criticisms about the lack of inclusion of LPNs, which are a backbone to every operator in the business. This they left that one number out there that you could fill with LPN, but that's not the same thing. But operators staff buildings based on acuity both in terms of total hours and in terms of the mix of those hours between RNs, LPNs, nursing assistants you've got facilities that bring in NPs. So -- any evidence that you look at we'll tell you pretty clearly that one size fits all does not work and does not lead to better quality outcomes. So just -- and in addition to that, putting an arbitrary number of what staffing should be does not -- there's no correlation between that and quality outcomes as well. So that's probably more than you needed to hear. But and what make sure, I covered all aspects of it.
Joshua Dennerlein: Yeah. Good color. I appreciate the time. I'll jump back in the queue. Thanks.
Operator: Your next question comes from the line of Michael Griffin of Citigroup. Your line is opens.
Michael Griffin: Great. Thanks. I wanted to touch a bit on the acquisition pipeline and sort of what you're seeing out there. Obviously you're not giving any speculative acquisitions in guidance. But if you annualize the midpoint of earnings this quarter gets you to kind of that low-end. So how are you thinking about acquisitions whether from a yield perspective? And how much do you think they contribute to earnings on a stabilized basis this year?
Talya Nevo-Hacohen: Well, I'll tell you what we're seeing, just to elaborate on what Rick, had said earlier. Deal flow is phase back up, but we're seeing a lot. I think we've said this in the past that, the best deals we're seeing are the ones that are coming to us off market. And I suspect that's true for our peers as well. We are focused more on the acquiring assets although we're open to doing some loans. That's not where we're focused. So we're seeing quite a bit, and we're seeing quite a bit from operators who we'd like to do repeat business. And that's really the key piece. How much we get done and wait to be seen. We'll keep everyone apprised of that. But we're -- but the contribution to 2024 is really going to be dependent on when we close in anything else. Rick mentioned that buyers' and sellers' pricing expectations have come much closer. That's generally true. And so the opportunity to deals exists and we're managing our balance sheet carefully, but we see opportunities that are worthwhile.
Michael Griffin: And then ….
Rick Matros: So the earlier…
Michael Griffin: Oh, sorry, go ahead Rick.
Rick Matros: The only other point of emphasis, I make is that our guidance as you know doesn't include any assumptions about acquisitions in my statement, in my opening remarks about revisiting guidance in the second quarter, because we're ahead of where we thought we'd be already has nothing to do with any assumptions about acquisitions this year. So that would just be great on top of that. But to Talya's point the reality is, if you're closing most of your stuff over the last five or six months of the year it's going to have more of a muted impact and just serves more to fuel growth going into 2025.
Michael Griffin: Great. That's helpful. And then just a quick follow-up on that Talya, are you seeing any more appetite for -- in the financing environment for SNFs? Is there any bridge to HUD financing that's out there at favorable terms?
Talya Nevo-Hacohen: We are seeing non-bank lenders interested in lending on a bridge to HUD basis in the theories bridge to HUD. We've not been targeting that segment. We've looked at it quite a bit in the past. Yeah and it's not cheap. The challenge that was different now than it was call it 1.5 years ago is that 1.5 years ago people were doing bridge to HUD lending, based on forward valuation that's pretty much gone now from cost of capital and we will work on cost of capital to the expense to do that.
Rick Matros: Yeah. And also to reiterate, our philosophy of loans have to change. That is we do loans really specifically in relation to the relationships, we have with operators. So how is it helpful in the current relationship when an operator is trying to grow? Is there a load to own opportunity here? So we really don't have interest even though we know there are opportunities our peers are doing it. And building a portfolio of loans.
Michael Griffin: Got you. That's helpful, Rick. And then one last one if I may. I know you touched on the implications of the minimum staffing mandate in a question earlier. But can you give any maybe concrete initiatives that the industry is looking at whether it's lobbying certain committees, trying to take litigation into different courts. I mean just kind of hard things that you're seeing on the ground as the industry gears up to fight this thing.
Rick Matros: Yes. So, I really can't talk about that too much other than to say that everything is in place. There is a bill on the hill. It's not to bipartisan support in terms of legal action. Much of the groundwork has been done there as well. So -- but beyond that I can't really say probably about anything else. And most of our focus or most of the industry is focused -- the trade association specifically is going to be on the legislative strategy.
Michael Griffin: Great. That’s it for me. Thanks for the time.
Operator: Your next question comes from the line of Vikram Malhotra from Mizuho. Your line is now open.
Vikram Malhotra: Good afternoon. Thanks for taking the questions. Just maybe going back to the first, just the quarter results. I just want to understand kind of how the sharp growth cadence trended. I think last call you mentioned January you saw 20-plus percent year-over-year growth and ended up at 9%. So I'm just wondering like what happened in Feb and March? And if you could, could you just give us a sense of how April has trended?
Talya Nevo-Hacohen: Well, I have some spot occupancies on April, and they are -- and the spot occupancies through the end of April are versus first quarter are about 1% to 1.5% higher. So occupancy is continuing to grow. REVPOR is -- I don't know -- I don't have spot over for REVPOR but we've seen continued growth there. And I think the big piece that we're seeing finally happen is expenses, specifically labor decelerate its growth. So while we're still seeing some incremental growth, largely it's the filling of vacant positions as opposed to labor wage growth. So I don't have an April -- cash NOI number for you to share at this point.
Michael Costa: And the other thing I'd say is, as we mentioned earlier and noted in the press release, there wasn't as if there was a big drop off in the quarter. It was simply a comp issue to the prior year quarter where repairs and maintenance will exceedingly low, and they're running at a normal run rate right now. And so, normalizing for that comp and those lower expenses, we would have been in mid-teens for our growth number for the quarter.
Talya Nevo-Hacohen: Yes. I also want to underscore another thing just to clarify. The same-store managed portfolio, that I spoke about a few minutes ago, is had 64 assets in it, right. It also includes the joint venture -- I’m sorry, joint ventures at share. The portfolio we talked about last quarter as same-store had 51 assets. So we're also talking about different pools here. So just add.
Vikram Malhotra: Would it be fair to say that given your team's comment about adjusted team's comment, like for the balance of the year -- I’m not asking for a specific number but that team comment like should hold true as we go through the year, whether it's 12 or 18, I don't know but like do you see an accelerating trajectory decelerating? How should we just think about the cadence of growth for the balance of the year?
Michael Costa: Yes. I mean it's going to be dependent on occupancy recovery, but I think what we have to continue to pivot back to reaffirm is we reaffirm guidance. And what we reported for first quarter is in line with what we had forecast for guidance. So I think that should provide all the information you need.
Rick Matros: We don't see any trends that growth that are going to get in the way of either meeting or exceeding guidance.
Vikram Malhotra: Yes. I mean it just sounded like you had earlier mentioned you exceeded kind of your expectations, but you're being conservative I guess just early on. And then it seems like the SHOP comp should get easier through the year given what you mentioned about expenses. So it sounds like you're -- I mean I'm not putting words in your mouth, but it sounds like if you take those components you could -- numbers could go higher but that's just the way I was thinking about it. Just to clarify on the acquisitions, could you -- let's just say you do see in the U.S. portfolios you like more real estate portfolios as opposed to loans can you just talk about how you're thinking about funding these going forward?
Michael Costa: Sure. I think it's going to be dependent on a couple of things. I think first off if we're looking at SNF deals given where our stock is trading currently relative to our NAV and just on a yield basis that is a source of capital we could use to fund SNF deals use that to match fund with our line of credit. To the extent there's any sales proceeds that come in there's not a ton out there still but there's always some sales proceeds in the normal course of business that will also be capital available for us to redeploy into other assets. And if we see SHOP deals or we see senior housing deals that we could pair up with skilled nursing deals when we look at that on a blended basis it would have to make sense on a blended base from a blended yield basis for us to use the ATM. But we think there's opportunity there as well when you look at the totality of our investment pipeline.
Vikram Malhotra: Got it. Okay. And then just sorry one last just to clarify. Any sense of the final the Medicare ruling that I think comes out when in June or July from the initial proposal? Any sense if the comments how the kind of push together number higher or how that plays out?
Rick Matros: We're still in the comment period and it will come out until August usually in the first week of August. So we'll see but I would anticipate it to be where it is now. I don't anticipate it being lower but I think the odds are greater that it stays where it is as opposed to going higher but not lower.
Vikram Malhotra: Got it. Okay. Thank you.
Operator: Your next question comes from the line of Rich Anderson of Wedbush. Please go ahead.
Rich Anderson: Hey, thanks. Good morning, everyone. So about to minimum staffing you had 46,000 comments CMS said thanks for that and went ahead with it anyway. I know a lot of your peers in the REITs and operators are saying we hope that they'll come to their senses and we can all agree it's crazy what the requests are here what the mandate would be. But what could possibly change CMS' direction now another 1,000 comments? I mean I don't want to understand what more the industry could do to change the direction? Or does it is it more of a political thing where if we have a change of administration maybe that incites a change. But separate from that how does this not go through as it stands today?
Rick Matro: We believe we can successfully address the issue legislatively. You're right they essentially ignored all the comments and they rush to get this out because there's no way even 40,000 to 50,000 comments that they could have thoughtfully reviewed all of those and not as far little out, what they did. So it's left the industry with no position -- with no option rather than to take legislative action and potentially legal action as well.
Rich Anderson: Okay. And then as it relates to your portfolio have you done any work to say well this percentage is subject to the three-year phase in this is five years and this -- this percentage might actually be exempt from the legislation as it currently stands. Have you done that work yet? Do you have an idea of what it might be from a geographic standpoint?
Rick Matro: No I think it's premature to do that work Rich not just because people are still recovering. But the impact of this if it doesn't go away is two year to five years out. So we've got some time right now to see if the remedies if you will that the industry is going to undertake to get rid of this mandate takes hold. I think there'll be plenty of time. If we succeed in that great. If we don't succeed in that effort we'll still have plenty of time to do as you suggest.
Rich Anderson: Okay. And then last for me switching to SHOP same-store. I understand comps in February and March and all that. But you said off to a good start in the first quarter going to take a look at guidance next quarter. It does SHOP figure into that as well? Is that outperforming? And I think you said in the line.
Rick Matro: Our SHOP is somewhat ahead of our internal forecast guidelines.
Rich Anderson: Okay. And your internal forecast guidance are for what on a same-store if you can remind me I just don't remember.
Michael Costa: Sorry, you're asking what our same-store NOI growth assumption in our guidance is?
Rich Anderson: Yes for SHOP.
Michael Costa: Yes. I mean like I answered it earlier on the call Rich, what we have talked about on previous calls was we didn't put that number out right? But what other folks are saying is mid-teens growth on an NOI basis year-over-year and that feels reasonable given our portfolio.
Rich Anderson: Okay. I'm sorry I missed that part of it. Thanks very much.
Operator: Your next question comes from the line of Alex Mejia [ph] of Baird. Your line is now open.
Unidentified Analyst: Thank you for taking my question. First one for me. Can you talk a little bit – give some color on maybe the NOI growth between IL and AL and where that's been trending?
Rick Matros: Well we're not going to give the specific numbers that I would say as we've talked about in the past. They are fundamentally different businesses. So the AL growth is going to be stronger than the IL growth simply because you've got more tools to impact the revenue line than you do in IL, which effectively isn't really a healthcare facility even though there's been Acuity clinic, which is why we got the PLR letter back in 2020. So – and the other point I would make is that the IO portfolio never got hit this hard during the pandemic as the AL, so there's less recovery to be had there.
Unidentified Analyst: Got it. And we noticed you combined the two and that occupancy was down quarter-over-quarter. Was that driven by any one of them more or less?
Michael Costa: No I think that was really just – we go through all of our disclosures periodically and especially in our supplement. And what we saw was that we were an outlier and given that level of granular detail. So we basically made our disclosures conform to what our peers show.
Unidentified Analyst: Got it. That’s it for me. Thank you.
Operator: Your next question comes from the line of Michael Stroyeck of Green Street. Please go ahead.
Michael Stroyeck: Thanks and good morning. Could you just share where spot occupancy and coverage levels for the SNF portfolio sit today? And then just assuming the company can get spot occupancy back to pre-COVID levels in that call it 82% range. How sizable of an impact would you expect for that to have on coverages?
Rick Matros: It's going to be pretty sizable. On the last call on our year-end call Rich Anderson asked it. Given that dynamic that you're talking about is it possibly going to get a consolidated two times coverage. And I'm not going to say as soon as we get there but it's clearly going to have a material impact on coverage with coverage higher now than pre-pandemic occupancy, our margins are back to where they were pre-pandemic occupancy, which means the pull-through of that operational leverage is actually settled in at a lower occupancy level. So that's all positive for us. So it's hard to sit here and say this is what the exact impact is going to be on coverage near two years from now of occupancy is 300 basis points higher but it's clearly going to have a material impact.
Michael Stroyeck: Got it. Okay. And then maybe just one more on the SHOP portfolio. How much labor vacancy is there in that portfolio? Or maybe said differently, is there still quite a bit of staffing in terms of headcount needed in order to be able to achieve the occupancy upside there?
Talya Nevo-Hacohen: I think the answer is no. I think that the opportunity to actually hire labor full time reduce over time and agency and it's been very important and has been very actionable. So I would say that based on what I've seen, our operators are already in 80% to 90% occupancy of the range on stabilized assets. And so your and they're all positioned to take advantage of operating leverage and alluding to a rate just then because they've staffed up to actually be able to sell.
Michael Costa: So no one's holding back on admissions because of labor issues in the SHOP portfolio.
Michael Stroyeck: Okay. Great. Thanks for the time.
Operator: [Operator Instructions] There are no further questions at this time. I turn the call back over to Rick Matros.
Rick Matros: Thank you all for joining us. We're always here available for additional conversations. If you were to talk offline. And in the meantime, hope you'll have a good day. Thank you.
Operator: This concludes today's conference call. You may now disconnect.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.